NCT04305444 2025-01-08Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasZhejiang DTRM BiopharmaPhase 2 Terminated55 enrolled
NCT00622258 2020-12-21A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaNovartisPhase 1 Completed13 enrolled